| B Acute Lymphoblastic Leukemia investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 80show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 79 trials (36 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 79 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 51 trials (22 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 48 trials (21 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal_antibody 46 trials (31 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 45 trials (19 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 43 trials (19 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 40 trials (18 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 34 trials (17 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 31 trials (14 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 28 trials (12 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 27 trials (11 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 26 trials (9 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 25 trials (10 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 19 trials (13 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 18 trials (9 active) · roll-up of the cancer and its descendants | — | — | B Acute Lymphoblastic Leukemia | 18 | Observed | clinicaltrials | graph → |